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Abstract
Objective—We assessed the contribution of increasing adiposity to the rising prevalence of 
diabetes in the United States over the period 1988–2014.
Research Design and Methods—Data from NHANES III (1988–1994) and continuous 
waves (1999–2014) were pooled for the current study. Diabetes status was assessed using data on 
Hemoglobin A1c. We estimated a multivariable logistic regression model that predicted the odds 
of having diabetes as a function of age, sex, racial/ethnic group, educational attainment, and period 
of observation. At a second stage, we introduced measures of general and abdominal adiposity into 
the model. Changes in coefficients pertaining to period of observation between the first and second 
models were interpreted as indicating the extent to which adiposity can account for trends in the 
prevalence of diabetes. Sensitivity analyses were conducted to investigate how alternative 
definitions of adiposity and diabetes status would affect results.
Results—The predicted prevalence of diabetes rose by 2.59% per year between 1988 and 2014 
after adjusting for changes in population composition. Increasing adiposity explained 72% of the 
rise in diabetes. Results were consistent for men and women.
Conclusions—Rising levels of adiposity explained the large majority of the rise in diabetes 
prevalence between 1988 and 2014.
The prevalence of diabetes has risen rapidly in the United States over the last several 
decades. The age-standardized proportion of US adults with diabetes more than doubled 
between 1990 and 2008, increasing from 3.5% to 7.9% over this interval.(1) The upward 
trend in diabetes persists regardless of whether trends are measured using self-reported data 
or a clinical marker of diabetes status, such as fasting plasma glucose (FPG) or hemoglobin 
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A1c (HbA1c).(1–3) Using these two clinical markers, the prevalence of diabetes among US 
adults reached 12.3% in 2011–12.(4)
A prominent explanation for the rise in diabetes prevalence is the increase in the proportion 
of the population that is overweight or obese.(5–7) Research on physiological mechanisms 
has identified a variety of potential pathways linking adiposity to diabetes, including 
activation by adipose tissue of free fatty acids and inflammatory cytokines.(8) Evidence 
from observational studies shows strong associations between general adiposity, measured 
using body mass index (BMI) and diabetes.(9) Waist circumference, a measure of abdominal 
adiposity, also shows an independent association with diabetes which rivals or exceeds in 
explanatory power the association between BMI and diabetes.(10–13)
Additional evidence comes from randomized trials, which have identified significant 
reductions in diabetes that were coincident with significant weight loss. One randomized 
trial found that patients assigned to bariatric surgery had significantly greater reductions in 
BMI, in HbA1c, and in fasting plasma glucose (FPG) than those assigned to medical 
therapy.(14) An earlier study of bariatric surgery found similar results with respect to weight 
loss and FPG when the comparison group included not only medical components but also 
caloric reduction.(15) Another study found that the relative risk of diabetes remission was 
5.5 times greater among patients randomly assigned to bariatric surgery compared to those 
receiving conventional therapy.(16)
A rising level of adiposity is not the only factor that has been proposed to account for the 
growing prevalence of diabetes. Related explanations focus specifically on declining levels 
of physical activity (17) or increases in per capita sugar consumption.(18,19) Increased 
environmental exposure to Bisphenol A as a result of greater use of plastics in food 
preservation has also been cited as a possible cause.(20) Demographic changes may have 
also contributed. Hispanics and the elderly represent growing fractions of the US population 
and both groups have an above-average prevalence of diabetes.(21,22)
Increased awareness of the disease and adoption of lower clinical thresholds for diagnosing 
diabetes may also have produced a rise in the frequency with which diabetes is diagnosed 
given a particular set of clinical conditions.(22) However, increased awareness of the disease 
could not account for changes in prevalence identified by a specific biomarker applied 
uniformly to a national sample. The prevalence of diabetes may have also increased because 
people with diabetes are living longer relative to people without diabetes. Even if the 
incidence of diabetes were not increasing, its prevalence would rise if relative survivorship 
improved.(23)
Several other factors may be operating in the opposite direction. Cigarette smoking is a risk 
factor for developing diabetes (24) and smoking is declining. Those with higher educational 
attainment have a lower prevalence of diabetes (25) and educational attainments are 
increasing.
In this study, we assess the strength of the relationship between adiposity and diabetes at the 
population level using nationally representative data from the United States. In particular, we 
investigate whether the magnitude of the increase in adiposity can account for the magnitude 
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of the rise in diabetes, in light of the individual-level relationship between adiposity and 
diabetes. We incorporate data on abdominal as well as general adiposity into the analysis 
given evidence that adnominal obesity may independently predict diabetes risk.(10–13) We 
also integrate data on weight history in addition to current weight status to capture potential 
cumulative effects of prior weight status and to account for any measurement error related to 
illness-induced weight loss.(26,27)
Research Design and Methods
The National Health and Nutrition Examination Survey (NHANES) is a nationally 
representative survey of the US population and includes a questionnaire as well as clinical 
and laboratory components. We combined data from the NHANES III (1988–1994) with 
data from the NHANES continuous waves collected in two-year cycles between 1999 and 
2014. (28,29) We restricted the sample to adults aged 35–79 with non-missing data on 
adiposity measures, HbA1c and educational attainment. We excluded individuals who were 
pregnant at the time of the exam and those with extreme values of adiposity. These 
restrictions resulted in a final analytic sample of 38,106 individuals.
We used the HbA1c criterion to define diabetes. HbA1c better reflects average glycemia and 
exhibits greater stability and lower variation within individuals compared to other diagnostic 
markers such as FPG.(2,30) Furthermore, because HbA1c does not require fasting, failure to 
fast prior to the test is not a source of measurement error. Finally, compared to FPG, which 
is only available for a subset of NHANES participants, HbA1c was collected on the full 
examined sample, increasing the precision of estimates. We used the American Diabetes 
Association (ADA) guidelines (30) to classify individuals with diabetes as having an HbA1c 
greater than 6.5%. We further classified as diabetic persons whose HbA1c values were 
below 6.5% but who reported use of an oral hypoglycemic agent or insulin. In a sensitivity 
analysis, we repeated our basic analysis using self-reported diagnosis of diabetes. We also 
examined trends when the population at high risk of diabetes (HbA1c > 6.1%) was included 
with the diabetic population.
We incorporated data on both general and abdominal adiposity into the analysis. For the 
latter, we used data on waist circumference (measured in cm) which was collected by trained 
health technicians in the examination component of the NHANES. For general adiposity, we 
considered four separate measures, including current BMI, maximum lifetime BMI (max 
BMI), BMI at age 25 and BMI 10 years prior to survey. Current BMI was calculated using 
weight and height measured at the NHANES examination. The weight history measures 
were constructed using information on recalled weight combined with measured height at 
survey. The weight history measures were introduced because they are less susceptible to 
reverse causation (26,27) and because studies have shown that adiposity measures at earlier 
stages of life are significant predictors of the incidence of diabetes, controlling later life 
values of adiposity.(31–33)
We estimated a multivariable logistic regression model, Model 1, that predicted the odds of 
having diabetes as a function of age (continuous), sex, racial/ethnic group (Non-Hispanic 
White, Non-Hispanic Black, Hispanic, and Other), educational attainment (less than high 
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school graduate, high school graduate, more than high school), and period of observation. 
We used two measures of period of observation: a continuous variable representing the 
midpoint year of the NHANES survey; and a set of dummy variables that distinguished 
between observations in NHANES III (1988–1994), chosen as the reference category, and 
those in NHANES continuous waves 1999–2002; 2003–2006; 2007–2010; and 2011–2014.
In the second stage, we estimated Model 2 by introducing adiposity measures into Model 1. 
We first introduced waist circumference into the model to capture abdominal obesity. We 
then introduced each of the four general adiposity measures into the model one variable at a 
time and evaluated model performance using the Akaike Information Criterion (AIC).(34) 
We limited selection to one variable from the four measures of general adiposity because the 
variables are highly collinear (see Supplemental Table 1). Changes in coefficients pertaining 
to period of observation between the first and second models indicated the extent to which 
adiposity can account for trends in the prevalence of diabetes.
In a preliminary analysis, we implemented a rescaling correction in the continuous time 
model to account for the fact that in nested logistic regression models, changes in 
coefficients may result both from mediation as well as from shifts in the scale of the model 
resulting from the introduction of a new variable.(35) As the estimates were not sensitive to 
the correction, we did not use it for our primary analyses. In an additional set of sensitivity 
analyses we examined (1) the effect of using self-reported data on diabetes status; (2) 
expanding the definition of diabetes to include those at high risk (HbA1c≥6.1); (3) using 
BMI at survey alone as the measure of adiposity; (4) stratifying analyses by sex; (5) 
including adjustment for smoking status (current, former, never) in the model.
Sample weights were incorporated to adjust for unequal probabilities of selection and non-
response. Analyses were performed using STATA 13 (StataCorp, Texas, USA). We used the 
SVY routine, which uses Taylor series linearization, to estimate variances.
Results
Table 1 shows the distribution of variables considered in this analysis during the five time 
periods that we distinguish. Mean waist circumference increased from 95.2 cm. in 1988–94 
to 101.2 in 2011–14. Each of the four variables referring to BMI also increased steadily over 
this period. The proportion Hispanic increased from 7.6% to 12.5%, while the proportion of 
the population who attended college grew from 41.1% to 63.6%.
Figure 1 presents the time trend in diabetes prevalence adjusted for changes in population 
composition. It is based on Model 1, a logistic regression predicting the odds of having 
diabetes as a function of age, sex, ethnicity, educational attainment, and period. The 
coefficients of Model 1 are presented in Supplemental Table 2. The predicted prevalence of 
diabetes in any particular period in Figure 1is based on the assumption that the distribution 
of variables, apart from period, is fixed at their mean values in 2011–14 while the coefficient 
pertaining to a particular period is unique to that period. The adjusted prevalence of diabetes 
rose from 7.4% in 1988–94 to 12.3% in 2011–14. We investigated whether time trends in 
diabetes prevalence were different for men and women by testing the significance of an 
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interaction term between time (continuous) and sex. The sex difference in trend was not 
significant. As a result, the sexes were combined in the remainder of our analysis. A 
sensitivity analysis shows the consequences of treating the sexes separately.
Supplemental Figure 1 presents A1C values for models that include various combinations of 
adiposity variables. The addition of waist circumference to Model 1 produced the greatest 
improvement in (i.e., reduction of) AIC. Once waist circumference was in the model, the 
addition of BMI 10 years before baseline was associated with the largest improvement in 
model performance among the four BMI measures examined. So Model 2, the coefficients 
of which are also presented in Supplemental Table 2, includes both waist circumference and 
BMI 10 years before survey.
Table 2 shows that the coefficient of “year of observation” in Model 1 is 1.0259; the odds of 
being diabetic increased by about 2.59% per year over the period from 1988 to 2014. The 
increase is statistically significant at p<.001. The increase was not strictly linear. Table 2 also 
presents the coefficients of categorical variables representing different periods, relative to 
odds ratios in 1988–94. Across the three decades, the prevalence of diabetes rose by 76%. 
The prevalence rose most rapidly between 2003–06 and 2007–10. However, the increase is 
monotonic and linearity remains a reasonable approximation over the entire period.
Table 2 also presents the time trends after the two adiposity variables have been controlled. 
The decline in the coefficient of “year of observation” across the two models implies that 
71.6% of the trend has been removed by controlling adiposity. When 1988–94 is used as the 
baseline, the Table shows that between 70% and 140% of the trend ending in different 
periods has been eliminated. Trends in the coefficients before and after adiposity is 
accounted for are shown graphically in Figure 2.
Sensitivity Analyses
1) Using Self-Reported Diagnosis of Diabetes—Some combination of increased 
awareness of diabetes and changing criteria for diagnosing it has reduced the proportion of 
cases with clinical diabetes that are undiagnosed. (3,22) Accordingly, we anticipated that 
diabetes prevalence would be rising faster when self-reports are used to identify it than when 
HbA1c is used. Table 3 shows that the annual increase in prevalence was slightly faster 
when self-reports are used (2.78%/yr) than when HbA1c is used (2.59%/yr). A somewhat 
smaller percentage of the increase was explained by adiposity when self-reports are used.
2) Using a measure that includes those at high risk of diabetes as well as 
those with diabetes—We investigated whether rising adiposity could also account for the 
rapid growth of individuals in the range of HbA1c values above 6.1%. Table 3 shows that the 
growth of population in this category is much faster at 3.09%/yr. than when the population is 
limited to those with diabetes itself, 2.59%/yr. And rising adiposity accounts for only 53% of 
the rapid growth in the prevalence of this combined category.
3) Using Only BMI at baseline—The most common indicator of adiposity used in 
studies of its health effects is BMI at survey. (26,27) We re-estimated Model 2 using only 
this indicator. Results shown in Table 3 indicate that changes in the distribution of BMI at 
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baseline account for a much smaller percentage of the increase in diabetes, 48%, than when 
our two preferred adiposity measures are used (72%).
4) Analyzing men and women separately—We did not find a significant sex 
interaction in the trend in diabetes prevalence. But sex differences are sufficiently interesting 
that we have re-estimated Models 1 and 2 separately for men and women. Results in Table 3 
show that the time trend in HbA1c prevalence is similar for men and women, with men’s 
prevalence rising by 2.40%/yr. and women’s by 2.83%/yr. Furthermore, a similar percentage 
of the trend for men and women is explained by adiposity: 73% for men and 68% for 
women.
5) Adding smoking to the model—Smoking is a potential confounder of the relation 
between adiposity and diabetes (14. 39). We introduce smoking (current, former, never) into 
Models 1 and 2 with results shown in Table 3. The introduction of smoking as an additional 
control in Model 1leaves the annual upward trend in diabetes virtually unchanged at 2.62% 
(vs. 2.59%).The percentage of the upward trend in diabetes explained by adiposity is also 
nearly unchanged at 70.7% (vs. 71.6%).
Discussion
Using HbA1c as the basic indicator of diabetes, we find that the prevalence of diabetes (i.e., 
the odds of having diabetes) has risen by about 2.59% per year between 1988–94 and 2011–
14. This growth rate is based on prevalence values that are adjusted for changes in the 
composition of the population with respect to age, sex, ethnicity, and educational attainment. 
When increases in adiposity over this time interval are accounted for, the prevalence of 
diabetes would have grown by only about 0.74% per year. So we conclude that rising 
adiposity accounts for about 72% of the rise in diabetes over this period. The estimated 
value of 72% is approximately the same for men and women and is robust to the inclusion of 
smoking in the basic model.
Our results for men and women differ from those of a previous analysis, which found that 
rising obesity accounted for all of the rise in diabetes for women but a little less than half of 
the rise for men over the period 1976–80 to 2007–10.(21) That analysis used a less precise 
measure of diabetes (a combination of self-reports and fasting plasma glucose) and a 
measure of adiposity that is more susceptible to reverse causation (BMI at survey). (26,27) 
Our sensitivity analyses demonstrated that use of self-reported diabetes and of BMI at 
survey produced a smaller assignment of responsibility to adiposity in diabetes trends than 
the measures used in this analysis. These differences may help account for the smaller 
contribution of obesity to diabetes trends for men that was found in the previous study. 
There is no obvious explanation of the difference in explanatory power for women, but one 
contributing factor may be that the increase in diabetes for women in this earlier study was 
less than half of that for men, whereas our results show that women had a somewhat faster 
increase than men (Table 3).
Strengths of this analysis include its use of data drawn from national probability samples 
that cover a period of 26 years, a period that saw very rapid increases in the prevalence of 
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diabetes. We were able to examine this trend controlling for changes in the composition of 
the population with respect to age, sex, race/ethnicity, and educational attainment. We also 
used a validated indicator of diabetes that was measured consistently over the period. 
Another strength is that systematic model selection criteria were employed to choose among 
four general adiposity measures rather than assuming a priori that one measure was superior. 
Our measures include an indicator of central adiposity and elements of an individual’s 
weight history, features that earlier research had shown to be predictive of diabetes 
incidence. We find that waist circumference and BMI 10 years earlier outperform BMI at 
survey with respect to both predicting the prevalence of diabetes at an individual level and 
accounting for national trends in diabetes prevalence.
The analysis also had several limitations. First, we were unable to differentiate between 
changes in the incidence of diabetes and changes in the relative survival of individuals with 
diabetes. Longitudinal data are required in order to make this distinction but there are no 
national data using biomarkers for diabetes that permit such an analysis. Second, because the 
BMI history measures were calculated using data on self-reported past weight status 
combined with measured height at exam, measurement error may be introduced as a result 
of both systematic underreporting of prior weight status as well as any age-related loss of 
height. Because these two sources of error are offsetting, the net direction of bias is difficult 
to predict. Our use of a continuous rather than categorical measure of BMI is likely to 
mitigate some of this bias.(36) Third, the measure of abdominal obesity used in this analysis, 
waist circumference, may be subject to reverse causation, a reduction in adiposity that is 
produced by illness, including diabetes itself.(27) If reverse causality is present, estimates of 
the impact of adiposity on diabetes would be biased downwards. One study found that there 
was no significant increase in diabetes incidence associated with loss of waist 
circumference, in contrast to a large increase associated with weight loss.(12) This result 
suggests that reverse causation may be a smaller source of bias for analyses using waist 
circumference than for analyses using body mass index. Finally, we did not estimate the 
contribution of adiposity net of dietary behaviors and physical inactivity and thus our results 
may partially reflect the contributions by these factors. Future studies focused on the 
independent contributions of these upstream determinants would be of interest.
Conclusion
We conclude that rising adiposity is the major factor in the increase in diabetes prevalence in 
the United States over the period from 1988 to 2014. While other influences were doubtless 
at work, we can account for the large majority of the rise in diabetes prevalence over this 
period through adiposity alone. This demonstration adds urgency to the search for ways to 
arrest and reverse the growing prevalence of obesity in the United States.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Adjusted Diabetes Prevalence for US Adults Aged 35–79 across NHANES Survey 
Periods
Diabetes prevalence in each survey period was standardized to the mean covariate values in 
2011–2014. Estimates were generated using predicted probabilities from a logit regression 
model. The survey periods were 1988–1994, 1999–2002, 2003–2006, 2007–2010 and 201–
2014.
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Figure 2. Odds Ratios Associated with Survey Period in Models Adjusted and Unadjusted for 
Adiposity Measures
Odds ratios from the unadjusted model include no control for adiposity measures; those 
from the adjusted model control for waist circumference and BMI 10 years prior to survey.
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Table 2
Odds Ratios Associated with Survey Period in Continuous and Discrete Time Models
Model 1 – Unadjusted Model 2 – Adjusted % Explained
Continuous Time 1.0259 1.0074 71.6
Discrete Time
 1988–1994 1.00 1.00 –
 1999–2002 1.13 0.95 140.1
 2003–2006 1.34 1.03 91.6
 2007–2010 1.63 1.19 70.3
 2011–2014 1.76 1.18 76.3
Odds ratios from Model 1 include no control for adiposity measures; those from Model 2 control for waist circumference and BMI 10 years prior to 
survey. For the continuous time models, observations are assigned to the midpoint of the survey wave. For the categorical models, survey periods 
are modeled using a series of indicator variables.
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Table 3
Analyses of Sensitivity of Results to Changes in Model Specifications
Sensitivity Analysis
Coef (Cts Time Variable)
% ExplainedModel 1 Model 2
Baseline Model 1.0259 1.0074 71.6
1. Using self-reported diagnosis of diabetes 1.0278 1.0102 63.3
2. Pre-diabetes & diabetes 1.0309 1.0144 53.4
3. Use of baseline BMI only 1.0259 1.0134 48.1
4. Analyses stratifying by gender
 A. Men 1.0240 1.0064 73.3
 B. Women 1.0283 1.0092 67.7
5. Adjustment for smoking status 1.0262 1.0077 70.7
Sensitivity analyses: 1: Self-reported data were ascertained at interview by asking respondents if they ever received a diagnosis of diabetes from a 
physician. 2: Individuals with diabetes (6.5%) or high risk for diabetes (6.1%) or below this threshold but currently on treatment for diabetes were 
included in the numerator. 3: Measured height and weight at survey were used to evaluate BMI. 4: Models were implemented with stratification on 
gender; 5: adjustment for smoking status was carried out using the categories never, former and current smoker.
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